' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

BRACHTL GABRIELE
Universitätsinstitut für experimentelle und klinische Zelltherapie
Zentrum für Querschnitt- und Geweberegeneration Salzburg

Publikationen | Forscherprofil

69 Publikationen

2018

Beiträge in Fachzeitschriften

Selection of Tissue Factor-Deficient Cell Transplants as a Novel Strategy for Improving Hemocompatibility of Human Bone Marrow Stromal Cells
Oeller, M; Laner-Plamberger, S; Hochmann, S; Ketterl, N; Feichtner, M; Brachtl, G; Hochreiter, A; Scharler, C; Bieler, L; Romanelli, P; Couillard-Despres, S; Russe, E; Schallmoser, K; Strunk, D
THERANOSTICS. 2018; 8(5): 1421-1434.
Originalarbeiten (Zeitschrift)
Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial.
Tripolt, NJ; Aberer, F; Riedl, R; Url, J; Dimsity, G; Meinitzer, A; Stojakovic, T; Aziz, F; Hödl, R; Brachtl, G; Strunk, D; Brodmann, M; Hafner, F; Sourij, H;
Cardiovasc Diabetol. 2018; 17(1):71
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Influence of Heparin on Gene Expression of Stromal Cells Derived from Different Tissues
Laner-Plamberger, S; Oeller, M; Kalathur, R; Poupardin, R; Hochmann, S; Brachtl, G; Pachler, K; Kreutzer, C; Strunk, D; Rohde, E; Schallmoser, K
TRANSFUSION. 2018; 58: 66A-67A.
Abstracts (Zeitschrift)
Plasma Rotational Thrombelastometry for Evaluation of Hemocompatibility of Human Umbilical Cord Derived Stromal Cells
Oeller, M; Laner-Plamberger, S; Brachtl, G; Rohde, E; Strunk, D; Schallmoser, K
TRANSFUSION. 2018; 58: 68A-69A.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Development of immunosuppressive iPSC-derived stromal cells for tissue regeneration.
Peking, P; Scharler, C; Ketterl, N; Hochreiter, A; Jürchott, K; Höfler, M; Brachtl, G; Wimmer, M; Wolf, M; Hochmann, S; Schallmoser, K; Volk, H-D; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.
NO IDENTICAL STROMAL CELLS: TRANSCRIPTOMIC META-ANALYSIS HIGHLIGHTS DIFFERENCES BETWEEN BONE-MARROW-DERIVED MESENCHYMAL STROMAL/PROGENITOR CELLS AND OTHER STROMAL CELL SOURCES.
Poupardin, R; Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Schallmoser, K; Strunk, D
6th Annual GSCN Conference; 19.-21.09.2018; Heidelberg. 2018.

2017

Beiträge in Fachzeitschriften

An RNA-targeted therapy for dystrophic epidermolysis bullosa.
Peking, P; Koller, U; Duarte, B; Murillas, R; Wolf, S; Maetzig, T; Rothe, M; Kocher, T; García, M; Brachtl, G; Schambach, A; Larcher, F; Reichelt, J; Bauer, JW; Murauer, EM;
Nucleic Acids Res. 2017; 45(17): 1025-10269.
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Regenerative potential of periosteum-derived stromal cells
Brachtl, G; Hochreiter, A; Hochmann, S; Mittermeir, M; Raninger, A; Schallmoser, K; Wittig, J; Gaggl, A; Strunk, D
Human Gene Therapy. 2017; 28: A89-A90.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
No identical stromal cells: Human stromal progenitors from non-skeletal sources display limited chondrogenic potential.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
Human Gene Therapy. 2017; 28: A84-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Human Platelet Lysate Modifications Affect Mesenchymal Stromal Cell Biology Depending on Cell Origin
Laner-Plamberger, S; Öller, M; Brachtl, G; Strunk, D; Hartl, A; Pachler, K; Feichtner, M; Hauser-Kronberger, C; Wiedemann, H; Rohde, E; Schallmoser, K
Vox Sanguinis. 2017; 112(1):285-286.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Viral antigen-specific pre-vaccination prevents engraftment of tumor cells expressing the cognate antigen in mice
Leb-Reichl, V; Kienzl, M; Stoecklinger, A; Kitzmueller, S; Gratz, IK; Brachtl, G; Zaborsky, N; Reichelt, J; Gruber, C; Hofbauer, JP
J INVEST DERMATOL. 2017; 137(10): S286-S286.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture conditions
Oeller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
TRANSFUS MED HEMOTH. 2017; 44: 74-74.
Abstracts (Zeitschrift)
Selection of tissue factor-deficient bone marrow stromal cell transplants as a novel strategy to improve therapeutic applicability
Oeller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk, D
Human Gene Therapy. 2017; 28: A97-A98.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)
Tissue Factor Expression and Hemocompatibility of Stromal Cells Depend on Organ Origin and Culture Conditions
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, Z; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Vox Sanguinis. 2017; 112(1):65-66.-27th Regional Congress of the International Society of Blood Transfusion; 17.06.-21.06.2017; Copenhagen.
Abstracts (Zeitschrift)
Hemocompatibility of stromal cells depends on tissue factor expression and is influenced by organ origin and culture
Öller, M; Laner-Plamberger, S; Feichtner, M; Brachtl, G; Dunai, ZA; Russe, E; Rohde, E; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2017; 44(Suppl.1):p.74--50.Jahrestagung der DGTI; 24.-27.10.2017; Köln.
Abstracts (Zeitschrift)
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways.
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
Human Gene Therapy. 2017; 28: A83-A84.-25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Human mesenchymal progenitors from non-skeletal adult sources display limited chondrogenic Differentiation.
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
ISSCR Annual Meeting; 14.-17.06.2017; Boston. 2017.
No Identical Stromal Cells: Human Stromal Progenitors from Non-Skeletal Sources Display Limited Chondrogenic Potential
Hochmann, S; Scharler, C; Textor, M; Mittermeir, M; Brachtl, G; Föttinger, P; Hochreiter, A; Schmidt-Bleek, K; Ellinghaus, A; Geissler, S; Duda, G; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Selection of tissue factor-deficient bone marrow stromal cell transplants as a novel strategy to improve therapeutic applicability
Öller, M; Laner-Plamberger, S; Ketterl, N; Feichtner, M; Raninger, A; Hochreiter, A; Brachtl, G; Dunai, ZA; Russe, E; Schulte, M; Rohde, E; Schallmoser, K; Strunk D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.
Stepwise maturation of human iPSC into clonogenic immunosuppressive mesodermal stromal progenitors identifies key immunomodulatory pathways
Scharler, C; Ketterl, N; Jürchott, K; Brachtl, G; Schallmoser, K; Volk, HD; Strunk, D
25th Anniversary Congress of the ESGCT; 17.-20.10.2017; Berlin. 2017.

2016

Beiträge in Fachzeitschriften

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study.
Rawstron, AC; Fazi, C; Agathangelidis, A; Villamor, N; Letestu, R; Nomdedeu, J; Palacio, C; Stehlikova, O; Kreuzer, KA; Liptrot, S; O"Brien, D; de Tute, RM; Marinov, I; Hauwel, M; Spacek, M; Dobber, J; Kater, AP; Gambell, P; Soosapilla, A; Lozanski, G; Brachtl, G; Lin, K; Boysen, J; Hanson, C; Jorgensen, JL; Stetler-Stevenson, M; Yuan, C; Broome, HE; Rassenti, L; Craig, F; Delgado, J; Moreno, C; Bosch, F; Egle, A; Doubek, M; Pospisilova, S; Mulligan, S; Westerman, D; Sanders, CM; Emerson, R; Robins, HS; Kirsch, I; Shanafelt, T; Pettitt, A; Kipps, TJ; Wierda, WG; Cymbalista, F; Hallek, M; Hillmen, P; Montserrat, E; Ghia, P;
Leukemia. 2016; 30(4):929-936
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Leukotriene receptor inhibition mobilizes human stem cells in vivo
Brachtl, G; Hochreiter, A; Jacobs, VR; Schafer, R; Strunk, D
HUM GENE THER. 2016; 27(11): A56-A56.
Abstracts (Zeitschrift)
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A65-A65.
Abstracts (Zeitschrift)
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs)
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A65.
Abstracts (Zeitschrift)
Influence of heparin on the genomic profile of human mesenchymal stromal/progenitor cells
Laner-Plamberger, S; Oller, M; Kalathur, R; Brachtl, G; Strunk, D; Feichtner, M; Hauser-Kronberger, C; Schallmoser, K; Rohde, E
HUM GENE THER. 2016; 27(11): A61-A61.
Abstracts (Zeitschrift)
Efficient expansion of mesenchymal stem/progenitor cells supported by fibrinogen-depleted pooled human platelet lysate
Oller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
HUM GENE THER. 2016; 27(11): A63-A64.
Abstracts (Zeitschrift)
Efficient Expansion of Mesenchymal Stromal Cells by Fibrinogen-Depleted Pooled Human Platelet Lysate
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Transfusion Medicine and Hemotherapy. 2016; 43(Suppl.1):71--49. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie ; 07.-10.09.2016; Nürnberg.
Abstracts (Zeitschrift)
Fibrinogen-Depleted Pooled Human Platelet Lysate for Efficient Expansion of Mesenchymal Stromal Cells
Öller, M; Laner-Plamberger, S; Feichtner, M; Dunai, ZA; Raninger, A; Gimona, M; Hartl, A; Hauser-Kronberger, C; Russe, E; Bieback, K; Rohde, E; Brachtl, G; Scharler, C; Strunk, D; Schallmoser, K
Vox Sanguinis. 2016; 111(Suppl. 1):285--34th International Congress of the ISBT ; 03.-08.09.2016; Dubai.
Abstracts (Zeitschrift)
Stepwise maturation of human iPS cells into clonogenic immunosuppressive mesenchymal stem/progenitor cells
Scharler, C; Ketterl, N; Hofler, M; Brachtl, G; Schallmoser, K; Strunk, D
HUM GENE THER. 2016; 27(11): A64-A64.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Jacobs, VR; Schäfer, R; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Jacobs, VR; Schäfer, R; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Leukotriene receptor inhibition mobilizes human stem cells in vivo.
Brachtl, G; Hochreiter, A; Schäfer, R; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.
Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Effect of different cell culture conditions on the growth and clonogenicity of MSPCs.
Brachtl, G; Raninger, A; Hochreiter, A; Schäfer, R; Schallmoser, K; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Rolle von Mesenchymalen Stammzellen in der Organregeneration & Immunmodulation.
Brachtl, G; Strunk, D
20. Jahressymposium der IGLD; 25.-27.02.2016; Hamburg. 2016.
MSPCs from non-skeletal adult sources have an altered chondrogenic regeneration potency.
Hochmann, S; Scharler, C; Textor, M; Brachtl, G; Föttinger, P; Hochreiter, A; Geissler, S; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Understanding the molecular landscape of human BM-derived MSPCs through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Understanding the molecular landscape of human bone marrow-derived mesenchymal stem/progenitor cells through meta-analysis.
Kalathur, RK; Brachtl, G; Jeevan-Raj, BP; Scharler, C; Reinisch, A; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
PMU Science Day; 24.06.2016; Salzburg. 2016.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Scharler, C; Schallmoser, K; Reinisch, A; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
4th Annual Meeting of the German Stem Cell Network (GSCN); 12.-14.09.2016; Hannover. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 27.10.2016; Salzburg. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
3rd PACT-Symposium: Designer Cells Go Clinic; 23.-24.09.2016; Wien. 2016.
Stepwise maturation of human iPS cells into immunosuppressive mesenchymal stem/progenitor cells.
Scharler, C; Ketterl, N; Höfler, M; Daheron, L; Brachtl, G; Schallmoser, K; Strunk, D
ESGCT and ISSCR Collaborative Congress; 18.-21.10.2016; Florenz. 2016.

2015

Beiträge in Fachzeitschriften

CXCL12-induced VLA-4 activation is impaired in trisomy 12 chronic lymphocytic leukemia cells: a role for CCL21.
Ganghammer, S; Hutterer, E; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, PW; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Kruschinski, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, TN;
Oncotarget. 2015; 6(14):12048-12060
Originalarbeiten (Zeitschrift)
A robust potency assay highlights significant donor variation of human mesenchymal stem/progenitor cell immune modulatory capacity and extended radio-resistance.
Ketterl, N; Brachtl, G; Schuh, C; Bieback, K; Schallmoser, K; Reinisch, A; Strunk, D;
Stem Cell Res Ther. 2015; 6: 236
Originalarbeiten (Zeitschrift)

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

A fluorescence-based screening system accelerates the design of RNA trans-splicing molecules for mRNA repair.
Kocher, T; Koller, U; Seyr, J; Hainzl, S; Mayer, E; Brachtl, G; Lener, T; Bauer, J; Wally, V; Murauer, E
J INVEST DERMATOL. 2015; 135: S60-S60.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Does Montelukast mobilize human stem/progenitor cells in vivo?.
Brachtl, G; Hochreiter, A; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
2nd Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 05.11.2015; Salzburg. 2015.
Introducing an animal serum-free potency assay to monitor immune modulation capacity of human mesenchymal stem/progenitor cells (MSPCs).
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk, D
3rd International Annual Conference of the German Stem Cell Network (GSCN); 09.-11.09.2015; Frankfurt. 2015.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Ketterl, N; Höfler, M; Brachtl, G; Schallmoser, K; Strunk D.
World Conference on Regenerative Medicine 2015; 21.-23.10.2015; Leipzig. 2015.

2014

Beiträge in Fachzeitschriften

The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl, G; Piñón Hofbauer, J; Greil, R; Hartmann, TN;
Ann Hematol. 2014; 93(3): 361-374.
Übersichtsarbeiten

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Chronic Lymphocytic Leukaemia Cells with Trisomy 12 Home to the Bone Marrow in a CXCR4-Independent Manner
Hutterer, E; Ganghammer, S; Hinterseer, E; Brachtl, G; Asslaber, D; Krenn, P; Girbl, T; Berghammer, P; Geisberger, R; Egle, A; Zucchetto, A; Gattei, V; Chigaev, A; Greil, R; Hartmann, T
Chronic Lymphocytic Leukaemia Cells with Trisomy 12 Home to the Bone Marrow in a CXCR4-Independent Manner. 2014; 79(6): 424-478.-Scandinavian Society for Immunology 42nd Annual Meeting; 11.-14.06.2014; Reykjavik.
Abstracts (Zeitschrift)
Bing Neel syndrome mimicking Lyme neuroborreliosis
Kalss, G; Trinka, E; Himmer, M; Brachtl, G; Muehlmann, J
EUR J NEUROL. 2014; 21: 619-619.
Abstracts (Zeitschrift)

Nichtpublizierte (nicht zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
U-derived stem/progenitor cells: A noninvasice cell source for regenerative purposes.
Brachtl, G; Schuh, C; Ketterl, N; Höfler, M; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.
Optimizing conditions to differentiate human induced pluripotent stem cells into mesenchymal stem/progenitor cells.
Höfler, M; Schuh, C; Ketterl, N; Brachtl, G; Strunk, D
International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Analyzing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G; Schuh, C; Schallmoser, K; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014. ; 13.11.2014; Salzburg. 2014.
Predicting and optimizing the immune modulation potential of human mesenchymal stem/progenitor cells.
Ketterl, N; Brachtl, G, Schuh, C; Schallmoser, K; Strunk, D
2nd International Annual Conference of the German Stem Cell Network (GSCN); 03.-05.11.2014; Heidelberg. 2014.
Optimizing conditions to differentiate human iPS cells into functional mesenchymal stem/progenitor cells.
Schuh, C; Höfler, M; Ketterl, N; Brachtl, G; Strunk, D
1st Research Conference of the Spinal Cord Injury & Tissue Regeneration Center Salzburg (SCI-TReCS); 13.11.2014; Salzburg. 2014.

2011

Beiträge in Fachzeitschriften

Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl, G; Sahakyan, K; Denk, U; Girbl, T; Alinger, B; Hofbauer, SW; Neureiter, D; Hofbauer, JP; Egle, A; Greil, R; Hartmann, TN;
PLoS One. 2011; 6(8):e23758
Originalarbeiten (Zeitschrift)

2010

Beiträge in Fachzeitschriften

Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer, SW; Piñón, JD; Brachtl, G; Haginger, L; Wang, W; Jöhrer, K; Tinhofer, I; Hartmann, TN; Greil, R;
Cancer Res. 2010; 70(18):7336-7344
Originalarbeiten (Zeitschrift)

2009

Beiträge in Fachzeitschriften

Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
Hartmann, TN; Grabovsky, V; Wang, W; Desch, P; Rubenzer, G; Wollner, S; Binsky, I; Vallon-Eberhard, A; Sapoznikov, A; Burger, M; Shachar, I; Haran, M; Honczarenko, M; Greil, R; Alon, R;
Cancer Res. 2009; 69(7):3121-3130
Originalarbeiten (Zeitschrift)
Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer, I; Weiss, L; Gassner, F; Rubenzer, G; Holler, C; Greil, R;
J Immunother. 2009; 32(3):302-309
Originalarbeiten (Zeitschrift)

2006

Beiträge in Fachzeitschriften

Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.
Tinhofer, I; Rubenzer, G; Holler, C; Hofstaetter, E; Stoecher, M; Egle, A; Steurer, M; Greil, R;
Blood. 2006; 108(9):2950-2956
Originalarbeiten (Zeitschrift)

2005

Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Expression levels of CD38 in tumor cells and T-cells are of prognostic value in B-CLL
Tinhofer, I; Rubenzer, G; Egle, A; Greil, R
BLOOD. 2005; 106(11): 347A-347A.
Abstracts (Zeitschrift)